Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults

Journal of Bone and Mineral Research

Volumn 14, Issue 7, 1999, Pages 1182-1188

  Murphy, M Gail ^a   Bach, M A ^a   Plotkin, D ^a   Bolognese, J ^a   Ng, J ^a   Krupa, D ^a   Cerchio, K ^a   Gertz, B J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; IBUTAMOREN;

ADULT; AGED; ARTICLE; BONE REMODELING; BONE TURNOVER; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GROWTH HORMONE RELEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; OSTEOBLAST; OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL; TRABECULAR BONE;

AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; BONE AND BONES; BONE REMODELING; COLLAGEN; COLLAGEN TYPE I; DISABLED PERSONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INDOLES; INSULIN-LIKE GROWTH FACTOR I; MALE; OSTEOCALCIN; PEPTIDES; SEX FACTORS; SPIRO COMPOUNDS;

EID: 0033047602     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1999.14.7.1182     Document Type: Article

References (29)

1. Sontag W 1986 Quantitative measurements of periosteal and cortical-endosteal bone formation and resorption in the midshaft of male rat femur. Bone 7:63-70.
2. Andreassen TT, Jorgensen PH, Flyvbjerg A, Orskov H, Oxlund H 1995 Growth hormone stimulates bone formation and strength of cortical bone in aged rats. J Bone Miner Res 10:1057-1067.
3. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO 1987 Effects of sex and age on the 24-hour profile of growth hormone secretion in man: Importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 64:51-58.
4. van Coevorden A, Mockel J, Laurent E, Kerkhofs M, L'Hermite-Baleriaux M, Decoster C, Neve P, Van Cauter E 1991 Neuroendocrine rhythms and sleep in aging men. Am J Physiol 260:E651-E661.
5. Veldhuis JD, Liem AY, South S, et al. 1995 Differential impact of age, sex steroid hormones and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescent assay. J Clin Endocrinol Metab 80:3209-3222.
6. Corpas E, Harman SM, Blackman MR 1993 Human growth hormone and human aging. Endocr Rev 14:20-39.
7. Ghiron L, Thompson JL, Holloway L, Hintz RL, Butterfield GE, Hoffman AR, Marcus R 1995 Effects of recombinant insulin-like growth factor-I and growth hormone on bone turn-over in elderly women. J Bone Miner Res 10:1844-1852.
8. Holloway L, Butterfield G, Hintz RL, Gesundheit N, Marcus R 1994 Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. J Clin Endocrinol Metab 79:470-479.
9. Marcus R, Butterfield G, Holloway L, Gilliland L, Baylink DJ, Hintz RL, Sherman BM 1990 Effects of short-term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab 70:519-527.
10. Whitehead HM, Boreham C, Mcllrath EM, Sheridan B, Kennedy L, Atkinson AB, Hadden DR 1992 Growth hormone treatment of adults with growth hormone deficiency: A result of a 13-month placebo-controlled cross-over study. Clin Endocrinol (Oxf) 36:45-52.
11. Brixen K, Kassem M, Nelsen H, Loft AG, Flyvbjerg A, Mosekilde L 1995 Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: A dose-response study. J Bone Miner Res 10:1865-1874.
12. Clemmesen B, Overgaard K, Riis B, Christiansen C 1993 Human growth hormone and growth hormone releasing hormone: A double-masked, placebo-controlled study of their effects on bone metabolism in elderly women. Osteoporos Int 3:330-336.
13. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Conn L, Rudman IW, Mattson DE 1990 Effects of human growth hormone in men over 60 years old. N Engl J Med 323:1-6.
14. Bravenboer N, Holzmann P, de Boer H, Roos JC, van der Veen EA, Lips P 1997 The effect of growth hormone (GH) on histomorphometric indices of bone structure and bone turn-over in GH-deficient men. J Clin Endocrinol Metab 82:1818-1822.
15. Holmes SJ, Whitehouse RW, Swindell R, Economou G, Adams JE, Shalet SM 1995 Effect of growth hormone replacement on bone mass in adult onset growth hormone deficiency. Clin Endocrinol 42:627-633.
16. Johannsson G, Rosen T, Bosaeus I, Sjostrom L, Bengtsson BA 1996 Two years of growth hormone (GH) increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. J Clin Endocrinol Metab 81:2865-2873.
17. Patchett AA, Nargund RP, Tata JR, et al. 1995 Design and biological activities of L-163,191 (MK-677): A potent, orally active growth hormone secretagogue. Proc Natl Acad Sci USA 92:7001-7005.
18. Bowers CY, Alster DK, Frentz JM 1992 The growth hormone-releasing activity of a synthetic hexapeptide in normal men and short statured children after oral administration. J Clin Endocrinol Metab 74:292-298.
19. Bowers CY, Reynolds GA, Durham D, Barrera CM, Pezzoli SS, Thorner MO 1990 Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab 70:975-982.
20. Ilson BE, Jorkasky DK, Curnow RT, Stote RM 1989 Effect of a new synthetic hexapeptide to selectively stimulate growth hormone release in healthy human subjects. J Clin Endocrinol Metab 69:212-214.
21. Smith RG, Pong S-S, Hickey G, Jacks T, Cheng K, Leonard R, Cohen CJ, Arena JP, Chang CH, Drisko J, Wyvratt M, Fisher M, Nargund R, Patchett A 1996 Modulation of pulsatile GH release through a novel receptor in hypothalamus and pituitary gland. Recent Prog Horm Res 51:261-286.
22. Copinschi G, van Onderbergen A, L'Hermite-Baleriaux M, Mendel CM, Gaufriez A, Leproult R, Bolognese JA, De Smet M, Thorner MO, van Cauter E 1996 Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I and adrenocortical function in normal young men. J Clin Endocrinol Metab 81:2776-2782.
23. Chapman IM, Bach MA, van Cauter E, Farmer M, Krupa D, Taylor AM, Schilling LM, Cole KY, Skiles EH, Pezzoli SS, Hartman ML, Veldhuis JD, Gormley GJ, Thorner MO 1996 Stimulation of the growth hormone (GH) - Insulin-like growth factor I axis by daily oral administration of a GH secretagogue (MK-677) in healthy elderly subjects. J Clin Endocrinol Metab 81:4249-4257.
24. Plotkin D, Ng J, Farmer M, Gelato M, Kaiser F, Kiel D, Korenman S, McKeever C, Munoz D, Schwartz R, Krupa D, Gormley G, Bach MA 1997 Use of MK-677, an oral growth hormone secretagogue, in frail elderly subjects. Endocrinol Metab 4 (Suppl A):35-36.
25. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB 1995 Lower extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 332:556-561.
26. Riggs BL, Melton LJ III 1986 Involutional osteoporosis. N Engl J Med 314:1676-1686.
27. Valk NK, Erdtsieck RJ, Algra D, Lamberts SW, Pols HA 1995 Combined treatment of growth hormone and the bisphosphonate pamidronate, versus treatment with GH alone, in GH-deficient adults: The effects on renal phosphate handling, bone turnover and bone mineral mass. Clin Endocrinol 43:317-324.
28. Erdtsieck RJ, Pols HAP, Valk NK, van Ouwerkerk BM, Lamberts SW, Mulder P, Birkenhager JC 1995 Treatment of post-menopausal osteoporosis with a combination of growth hormone and pamidronate: A placebo-controlled trial. Clin Endocrinol 43:557-565.
29. Holloway L, Kohlmeier L, Kent K, Marcus R 1997 Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women. J Clin Endocrinol Metab 84:1111-1117.